Section 1342.72 - Combination antiretroviral drug treatments for prevention of AIDS/HIV; reliance on multitablet drug regimen(a) For combination antiretroviral drug treatments that are medically necessary for the prevention of AIDS/HIV, a health care service plan shall not have utilization management policies or procedures, including a standard of care, which rely on a multitablet drug regimen instead of a single-tablet drug regimen unless, consistent with clinical guidelines and peer-reviewed scientific and medical literature, the multitablet regimen is clinically equally or more effective and equally or more likely to result in adherence to a drug regimen.(b) This section does not apply to a health care service plan contract with the State Department of Health Care Services.(c) This section shall remain in effect only until January 1, 2023, and as of that date is repealed, unless a later enacted statute that is enacted before January 1, 2023, deletes or extends that date.Ca. Health and Saf. Code § 1342.72
Added by Stats 2018 ch 787 (SB 1021),s 3, eff. 1/1/2019.